Loading
Please wait while we load your information from QuoteMedia.
Loading
Please wait while we load your information from QuoteMedia.
Please wait while we load your information from QuoteMedia.
Please wait while we load your information from QuoteMedia.
Please wait while we load your information from QuoteMedia.
As of January 5, 2025 • 4:00 PM ET
Date/Time | Source | News Release |
---|---|---|
12/12/2024 07:30 AM EST | GlobeNewswire | Conduit Pharmaceuticals to Revolutionize Drug Development Through Agreement to Use Artificial Intelligence and Cybernetics |
11/21/2024 07:30 AM EST | GlobeNewswire | Conduit Pharmaceuticals Receives Further Patent Approval For Lead Asset Targeting Autoimmune Disorders |
11/19/2024 04:30 PM EST | GlobeNewswire | Conduit Pharmaceuticals Announces Appointment of Simon Fry to Board of Directors |
11/04/2024 07:30 AM EST | GlobeNewswire | Conduit Pharmaceuticals Announces New Addition to its Autoimmune Pipeline |
11/01/2024 04:45 PM EDT | GlobeNewswire | Conduit Pharmaceuticals Announces Debt Restructuring and Additional Notes |
As of January 5, 2025 • 4:00 PM ET
Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.